Cosmos Health (COSM) Share-based Compensation (2011 - 2026)
Cosmos Health's (COSM) quarterly Share-based Compensation came in at $8.1 million in Q2 2026, down 37.71% on a YoY basis from $12.9 million in Q2 2025, and down 37.71% quarter-over-quarter from $12.9 million in Q1 2026.
Analysis
Cosmos Health (COSM) Share-based Compensation (2011 - 2026) Analysis & Trends
Cosmos Health (COSM) has reported Share-based Compensation for 14 consecutive years, with $8.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Share-based Compensation fell 37.71% year-over-year to $8.1 million; the trailing twelve-month figure through Jun 2026 stood at $8.1 million (down 37.71% YoY), and the FY2025 full-year result was $12.9 million, changed 0.0% from the prior year.
- Share-based Compensation retreated to $8.1 million in Q2 2026 per COSM's latest filing, from $12.9 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $13.4 million in Q3 2024 and bottomed at -$1.5 million in Q4 2025.
- Historically, Share-based Compensation has averaged $5.5 million across 5 years, with a median of $3.4 million in 2023.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation soared 196195.29% in 2023, then plunged 361.81% in 2025.
- Over 5 years, Share-based Compensation stood at -$2820.0 in 2022, then jumped by 12987.45% to $363426.0 in 2023, then soared by 61.38% to $586512.0 in 2024, then slumped by 361.81% to -$1.5 million in 2025, then surged by 624.4% to $8.1 million in 2026.
- According to Business Quant data, Share-based Compensation over the past three periods registered $8.1 million, $12.9 million, and -$1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | 40.00 Mn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 30.40 Mn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | 1.02 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 176,000.00 |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 54.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | 2.92 Mn |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | 11.41 Mn |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 29.30 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | 7.04 Mn |
| 10 | Cosmos Health | 15.08 Mn | 12.63 Mn | 1.51 Mn | 8.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.05 Mn |
| Mar 31, 2026 | 12.93 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Sep 30, 2025 | 12.93 Mn |
| Jun 30, 2025 | 12.93 Mn |
| Mar 31, 2025 | 12.93 Mn |
| Dec 31, 2024 | 586,512.00 |
| Sep 30, 2024 | 13.43 Mn |
| Jun 30, 2024 | 8.56 Mn |
| Mar 31, 2024 | 340,194.00 |
| Dec 31, 2023 | 363,426.00 |
| Sep 30, 2023 | 6.12 Mn |
| Jun 30, 2023 | 104,869.00 |
| Dec 31, 2022 | -2,820.00 |
| Sep 30, 2022 | 3,120.00 |
| Jun 30, 2022 | 24,101.00 |
| Dec 31, 2021 | 756,924.00 |
| Sep 30, 2021 | 1.99 Mn |
| Jun 30, 2021 | 1.97 Mn |
| Mar 31, 2021 | 1.19 Mn |